HSPA6 Confers Lenvatinib Resistance in Hepatocellular Carcinoma by Promoting Phase Separation-Mediated TXNRD1 Stabilization to Suppress Ferroptosis.

待确认 40 由月月鸟发布于 2026/8/28 14:35:16

DOI:10.1158/0008-5472.CAN-26-0314
文献类型：期刊论文
补充材料：仅需补充材料
文献链接：https://doi.org/10.1158/0008-5472.CAN-26-0314

American Association for Cancer Research (AACR)

Abstract：The development of therapy resistance compromises the long-term efficacy of lenvatinib in advanced hepatocellular carcinoma (HCC), highlighting the need to characterize the molecular drivers

应助信息

等待求助人确认

求助人未确认前，本求助不能再次应助。36小时后系统将自动确认应助成功。本求助将自动关闭。

7小时前

arbase

202608291237380886636.pdf

1天前

Book学术机器人

2026/8/28 14:35:28 未找到该文献，机器人已退出，请等待人工下载

2026/8/28 14:35:16 Book学术AI机器人收到请求，开始寻找文献

2026/8/28 14:35:16 已向机器人发送请求

1天前

月月鸟发布求助

上一个求助:其它数据库Naturally Fractured Carbonate Reservoir Characterization: A Case Study of a Mature High-Pour Point Oil Field in Hungary 下一个求助:NatureOrigins and consequences of oncogenic 3D chromatin remodelling.